Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II
Cannabis Law Report
JANUARY 20, 2022
ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Founded in 2013, Eleusis is dedicated to transforming psychedelics into medicines. About Eleusis. Bill@silverspikecap.com 212-905-4933.
Let's personalize your content